Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia

In this provocative commentary, we consider several questions posed by the late chronic myeloid leukaemia (CML) expert Prof. Michele Baccarani, which he challenged us to address after his death. He noted only a small proportion of people with chronic phase CML receiving tyrosine kinase-inhibitor (TK...

Descripción completa

Detalles Bibliográficos
Autores principales: Baccarani, Michele, Bonifazi, Francesca, Soverini, Simona, Castagnetti, Fausto, Gugliotta, Gabriele, Saber, Wael, Estrada-Merly, Noel, Rosti, Gianantonio, Gale, Robert Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061294/
https://www.ncbi.nlm.nih.gov/pubmed/35338251
http://dx.doi.org/10.1038/s41375-022-01522-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061294/
https://www.ncbi.nlm.nih.gov/pubmed/35338251
http://dx.doi.org/10.1038/s41375-022-01522-3

Ejemplares similares